16 Apr 2015 15:07
The chairman of Immunodiagnostic Systems has decided to follow the company's chief executive (CEO) and step down after the AIM-listed firm's declining first-half revenues and profits highlighted the difficulties affecting its strategy. Half-year results, which had been previewed by the group in mid-
Read moreAnglo Pacific: FinnCap upgrades to buy with a target price of 158p. Peel Hunt shifts target price from 196p to 198p retaining its buy recommendation. Ashmore: Canaccord Genuity upgrades from sell to hold with a target price of 300p. Numis cuts target price from 369p to 355p retaining an add rating.
Read more